QQQ   431.84 (+0.18%)
AAPL   169.64 (-1.77%)
MSFT   415.59 (+0.47%)
META   501.50 (+0.25%)
GOOGL   154.73 (-0.08%)
AMZN   183.76 (+0.08%)
TSLA   157.01 (-2.77%)
NVDA   877.84 (+2.07%)
AMD   163.59 (+2.04%)
NIO   3.85 (-1.03%)
BABA   69.86 (-1.08%)
T   16.07 (-1.05%)
F   12.16 (-0.57%)
MU   122.21 (+0.69%)
GE   156.35 (+1.72%)
CGC   6.71 (-3.87%)
DIS   113.93 (+0.87%)
AMC   2.78 (+12.55%)
PFE   25.76 (-0.58%)
PYPL   63.72 (+0.33%)
XOM   118.77 (-0.76%)
QQQ   431.84 (+0.18%)
AAPL   169.64 (-1.77%)
MSFT   415.59 (+0.47%)
META   501.50 (+0.25%)
GOOGL   154.73 (-0.08%)
AMZN   183.76 (+0.08%)
TSLA   157.01 (-2.77%)
NVDA   877.84 (+2.07%)
AMD   163.59 (+2.04%)
NIO   3.85 (-1.03%)
BABA   69.86 (-1.08%)
T   16.07 (-1.05%)
F   12.16 (-0.57%)
MU   122.21 (+0.69%)
GE   156.35 (+1.72%)
CGC   6.71 (-3.87%)
DIS   113.93 (+0.87%)
AMC   2.78 (+12.55%)
PFE   25.76 (-0.58%)
PYPL   63.72 (+0.33%)
XOM   118.77 (-0.76%)
QQQ   431.84 (+0.18%)
AAPL   169.64 (-1.77%)
MSFT   415.59 (+0.47%)
META   501.50 (+0.25%)
GOOGL   154.73 (-0.08%)
AMZN   183.76 (+0.08%)
TSLA   157.01 (-2.77%)
NVDA   877.84 (+2.07%)
AMD   163.59 (+2.04%)
NIO   3.85 (-1.03%)
BABA   69.86 (-1.08%)
T   16.07 (-1.05%)
F   12.16 (-0.57%)
MU   122.21 (+0.69%)
GE   156.35 (+1.72%)
CGC   6.71 (-3.87%)
DIS   113.93 (+0.87%)
AMC   2.78 (+12.55%)
PFE   25.76 (-0.58%)
PYPL   63.72 (+0.33%)
XOM   118.77 (-0.76%)
QQQ   431.84 (+0.18%)
AAPL   169.64 (-1.77%)
MSFT   415.59 (+0.47%)
META   501.50 (+0.25%)
GOOGL   154.73 (-0.08%)
AMZN   183.76 (+0.08%)
TSLA   157.01 (-2.77%)
NVDA   877.84 (+2.07%)
AMD   163.59 (+2.04%)
NIO   3.85 (-1.03%)
BABA   69.86 (-1.08%)
T   16.07 (-1.05%)
F   12.16 (-0.57%)
MU   122.21 (+0.69%)
GE   156.35 (+1.72%)
CGC   6.71 (-3.87%)
DIS   113.93 (+0.87%)
AMC   2.78 (+12.55%)
PFE   25.76 (-0.58%)
PYPL   63.72 (+0.33%)
XOM   118.77 (-0.76%)

AbCellera Biologics (ABCL) Earnings Date, Estimates & Call Transcripts

$4.05
-0.13 (-3.11%)
(As of 03:40 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 7
After Market Closes
Confirmed
Actual EPS
(Feb. 20)
-$0.17 Missed By -$0.03
Consensus EPS
(Feb. 20)
-$0.14
Skip Charts & View Estimated and Actual Earnings Data

ABCL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABCL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

AbCellera Biologics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.14)($0.08)($0.11)
Q2 20243($0.14)($0.09)($0.11)
Q3 20243($0.13)($0.09)($0.12)
Q4 20243($0.13)($0.09)($0.12)
FY 202412($0.54)($0.35)($0.46)
Q1 20251($0.11)($0.11)($0.11)
Q2 20251($0.12)($0.12)($0.12)
Q3 20251($0.15)($0.15)($0.15)
Q4 20251($0.13)($0.13)($0.13)
FY 20254($0.51)($0.51)($0.51)

ABCL Earnings Date and Information

AbCellera Biologics last announced its quarterly earnings results on February 20th, 2024. The reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.14) by $0.03. The business had revenue of $9.18 million for the quarter, compared to the consensus estimate of $9.58 million. AbCellera Biologics has generated ($0.52) earnings per share over the last year (($0.52) diluted earnings per share). Earnings for AbCellera Biologics are expected to decrease in the coming year, from ($0.65) to ($0.69) per share. AbCellera Biologics has confirmed that its next quarterly earnings report will be published on Tuesday, May 7th, 2024. AbCellera Biologics will be holding an earnings conference call on Tuesday, May 7th at 5:00 PM Eastern. Interested parties can register for or listen to the call..

AbCellera Biologics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/7/2024
Confirmed)
-------  
2/20/2024Q4 2023($0.14)($0.17)($0.03)($0.17)$9.58 million$9.18 million
11/2/2023Q3 2023($0.14)($0.10)+$0.04($0.10)$11.92 million$6.60 million
8/3/2023Q2 2023($0.13)($0.11)+$0.02($0.11)$12.38 million$10.10 million      
5/4/2023Q1 2023($0.12)($0.14)($0.02)($0.14)$12.11 million$12.20 million    
2/21/2023Q4 2022$0.01($0.10)($0.11)($0.10)$50.80 million$21.50 million    
11/8/2022Q3 2022$0.09$0.08($0.01)$0.08$77.19 million$101.38 million
8/9/2022Q2 2022$0.04($0.02)($0.06)($0.02)$61.22 million$45.90 million    
5/10/2022Q1 2022$0.47$0.54+$0.07$0.54$208.96 million$316.58 million    
2/24/2022Q4 2021$0.21$0.19($0.02)$0.19$122.05 million$139.30 million    
11/8/2021Q3 2021($0.05)($0.08)($0.03)($0.08)$10.51 million$5.51 million    
8/11/2021Q2 2021$0.08$0.03($0.05)($0.01)$71.99 million$27.64 million    
5/12/2021Q1 2021$0.37$0.37-$0.37$199.43 million$202.74 million  

AbCellera Biologics Earnings - Frequently Asked Questions

When is AbCellera Biologics's earnings date?

AbCellera Biologics has confirmed that its next quarterly earnings data will be published on Tuesday, May 7th, 2024. Learn more on ABCL's earnings history.

Did AbCellera Biologics beat their earnings estimates last quarter?

In the previous quarter, AbCellera Biologics (NASDAQ:ABCL) missed the analysts' consensus estimate of ($0.14) by $0.03 with a reported earnings per share (EPS) of ($0.17). Learn more on analysts' earnings estimate vs. ABCL's actual earnings.

How much revenue does AbCellera Biologics generate each year?

AbCellera Biologics (NASDAQ:ABCL) has a recorded annual revenue of $38.03 million.

How much profit does AbCellera Biologics generate each year?

AbCellera Biologics (NASDAQ:ABCL) has a recorded net income of -$146.40 million. ABCL has generated -$0.52 earnings per share over the last four quarters.

What is AbCellera Biologics's EPS forecast for next year?

AbCellera Biologics's earnings are expected to decrease from ($0.65) per share to ($0.69) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ABCL) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners